Dr. Kendra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2050 Kenny Rd
Tower 4th Floor
Columbus, OH 43221Phone+1 614-293-4320Fax+1 614-293-2584- Is this information wrong?
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1993 - 1998- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1990 - 1993
Rush Medical College of Rush University Medical CenterClass of 1990
Certifications & Licensure
OH State Medical License 2001 - 2024
NY State Medical License 1998 - 2002
WI State Medical License 1991 - 2001- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer Start of enrollment: 2005 Feb 25
- Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Start of enrollment: 2012 Nov 09
- Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Start of enrollment: 2013 Jul 12
- Join now to see all
Publications & Presentations
PubMed
- Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase.Savardekar, H., Allen, C., Jeon, H., Li, J., Quiroga, D., Schwarz, E., Wu, R., Zelinskas, S., Lapurga, G., Abreo, A., Stiff, A., Shaffer, J., Blaser, B., Old, M., Weso...> ;Molecular Cancer Research. 2024 Mar 1
- Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung Cancer.Alexander Wong, Maria Riley, Songzhu Zhao, Jessica Zimmer, Matthew Viveiros, Jing Gennie Wang, Vincent Esguerra, Mingjia Li, Gabrielle Lopez, Kari Kendra, David P Carb...> ;Journal of the National Comprehensive Cancer Network. 2023 Nov 1
- BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy.Steven H Sun, Colin D Angell, Himanshu Savardekar, Debasish Sundi, David Abood, Brooke Benner, Mallory J DiVincenzo, Megan Duggan, Fouad Choueiry, Thomas Mace, Prashan...> ;Cancer Immunology, Immunotherapy. 2023 Nov 1
- Join now to see all
Journal Articles
- Prognostic Gene Expression Profiling in Cutaneous MelanomaDouglas Grossman, Sancy A Leachman, Larissa Korde, Elizabeth I Buchbinder, Emily Y Chu, Julia A Curtis, Laura K Ferris, Kenneth F Grossmann, Siwen Hu-Lieskovan, Joanne..., JAMA Dermatology
Authored Content
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
Press Mentions
AACR Annual Meeting 2023: Therapy Advances for Patients with Rare Melanoma TypesMay 18th, 2023- Desmoplastic Melanoma Patients Respond "Exceptionally" Well to Treatment with Immunotherapy AloneMay 5th, 2023
- Rare Melanoma Very Likely to Respond to Treatment with PembrolizumabMay 5th, 2023
- Join now to see all
Hospital Affiliations
Ohio State University Wexner Medical CenterColumbus, Ohio
The OSUCCC - JamesColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
